FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3172507606> ?p ?o ?g. }

• W3172507606 endingPage "787.e21" @default.
• W3172507606 startingPage "787.e17" @default.
• W3172507606 abstract "Metastatic bladder cancer is an aggressive disease that can often be difficult to diagnose and stage with conventional cross-sectional imaging. The primary objective of this study was to determine the clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose (18F-FDG) PET/MRI for surveillance and restaging of patients with muscle-invasive, locally advanced, and metastatic bladder cancer compared to conventional imaging methods.This retrospective study enrolled patients with muscle-invasive, locally advanced and metastatic bladder cancer in a single institute evaluated with 18F-FDG PET/MRI. All patients also underwent conventional imaging with CT. Additional imaging may also have included 18F-FDG PET/CT (18F-FDG PET), or sodium fluoride (NaF) PET/CT in some patients. Images were reviewed by a diagnostic radiologist/nuclear medicine physician. Number of lesions and sites of disease were captured and compared between 18F-FDG PET/MRI and conventional imaging. Lesions were confirmed by sequential imaging or lesion biopsy. All patients were followed for survival.Fifteen patients (4 for surveillance; 11 for restaging) underwent 34 18F-FDG PET/MRI scans. Each patient received a corresponding conventional CT around the time of the 18F-FDG PET/MRI (median 6 days). The 15 patients (11 male; 4 female) had a median age of 61.5 years (range 37-73) and histologies of urothelial carcinoma (n = 13) and small-cell carcinoma of the bladder (n = 2) diagnosed as stage 4 (n = 13), stage 3 (n = 1), or stage 2 (n = 1). 18F-FDG PET/MRI detected 82 metastatic malignant lesions involving lymph nodes (n = 22), liver (n = 10), lung (n = 34), soft tissue (n = 12), adrenal glands (n = 1), prostate (n = 1), and bone (n = 2) with a resultant advantage of 36% for lesion visibility in comparison with CT. Serial imaging or biopsy confirmed these lesions as malignant.18F-FDG PET/MRI can detect metastatic lesions which cannot be identified on conventional CT, and this can allow for better treatment planning and improved disease monitoring during therapy." @default.
• W3172507606 created "2021-06-22" @default.
• W3172507606 creator A5001597397 @default.
• W3172507606 creator A5009772670 @default.
• W3172507606 creator A5022455023 @default.
• W3172507606 creator A5032317350 @default.
• W3172507606 creator A5039083730 @default.
• W3172507606 creator A5044239219 @default.
• W3172507606 creator A5047686363 @default.
• W3172507606 creator A5053073226 @default.
• W3172507606 creator A5082205914 @default.
• W3172507606 creator A5082981312 @default.
• W3172507606 date "2021-11-01" @default.
• W3172507606 modified "2023-10-01" @default.
• W3172507606 title "Clinical value of 18FDG PET/MRI in muscle-invasive, locally advanced, and metastatic bladder cancer" @default.
• W3172507606 cites W1585769594 @default.
• W3172507606 cites W1992657888 @default.
• W3172507606 cites W2001406831 @default.
• W3172507606 cites W2005058208 @default.
• W3172507606 cites W2019435160 @default.
• W3172507606 cites W2053622035 @default.
• W3172507606 cites W2088733137 @default.
• W3172507606 cites W2113560885 @default.
• W3172507606 cites W2148384441 @default.
• W3172507606 cites W2209310988 @default.
• W3172507606 cites W2460495182 @default.
• W3172507606 cites W2532548394 @default.
• W3172507606 cites W2612230857 @default.
• W3172507606 cites W2800613296 @default.
• W3172507606 cites W2945196281 @default.
• W3172507606 cites W2968041467 @default.
• W3172507606 cites W2999417355 @default.
• W3172507606 cites W3001563109 @default.
• W3172507606 cites W3035783975 @default.
• W3172507606 doi "https://doi.org/10.1016/j.urolonc.2021.04.024" @default.
• W3172507606 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34140245" @default.
• W3172507606 hasPublicationYear "2021" @default.
• W3172507606 type Work @default.
• W3172507606 sameAs 3172507606 @default.
• W3172507606 citedByCount "12" @default.
• W3172507606 countsByYear W31725076062021 @default.
• W3172507606 countsByYear W31725076062022 @default.
• W3172507606 countsByYear W31725076062023 @default.
• W3172507606 crossrefType "journal-article" @default.
• W3172507606 hasAuthorship W3172507606A5001597397 @default.
• W3172507606 hasAuthorship W3172507606A5009772670 @default.
• W3172507606 hasAuthorship W3172507606A5022455023 @default.
• W3172507606 hasAuthorship W3172507606A5032317350 @default.
• W3172507606 hasAuthorship W3172507606A5039083730 @default.
• W3172507606 hasAuthorship W3172507606A5044239219 @default.
• W3172507606 hasAuthorship W3172507606A5047686363 @default.
• W3172507606 hasAuthorship W3172507606A5053073226 @default.
• W3172507606 hasAuthorship W3172507606A5082205914 @default.
• W3172507606 hasAuthorship W3172507606A5082981312 @default.
• W3172507606 hasBestOaLocation W31725076061 @default.
• W3172507606 hasConcept C121608353 @default.
• W3172507606 hasConcept C126322002 @default.
• W3172507606 hasConcept C126838900 @default.
• W3172507606 hasConcept C143409427 @default.
• W3172507606 hasConcept C146357865 @default.
• W3172507606 hasConcept C151730666 @default.
• W3172507606 hasConcept C199374082 @default.
• W3172507606 hasConcept C2775842073 @default.
• W3172507606 hasConcept C2775934546 @default.
• W3172507606 hasConcept C2780352672 @default.
• W3172507606 hasConcept C2989005 @default.
• W3172507606 hasConcept C71924100 @default.
• W3172507606 hasConcept C86803240 @default.
• W3172507606 hasConceptScore W3172507606C121608353 @default.
• W3172507606 hasConceptScore W3172507606C126322002 @default.
• W3172507606 hasConceptScore W3172507606C126838900 @default.
• W3172507606 hasConceptScore W3172507606C143409427 @default.
• W3172507606 hasConceptScore W3172507606C146357865 @default.
• W3172507606 hasConceptScore W3172507606C151730666 @default.
• W3172507606 hasConceptScore W3172507606C199374082 @default.
• W3172507606 hasConceptScore W3172507606C2775842073 @default.
• W3172507606 hasConceptScore W3172507606C2775934546 @default.
• W3172507606 hasConceptScore W3172507606C2780352672 @default.
• W3172507606 hasConceptScore W3172507606C2989005 @default.
• W3172507606 hasConceptScore W3172507606C71924100 @default.
• W3172507606 hasConceptScore W3172507606C86803240 @default.
• W3172507606 hasFunder F4320306134 @default.
• W3172507606 hasFunder F4320308398 @default.
• W3172507606 hasFunder F4320332161 @default.
• W3172507606 hasFunder F4320332193 @default.
• W3172507606 hasIssue "11" @default.
• W3172507606 hasLocation W31725076061 @default.
• W3172507606 hasLocation W31725076062 @default.
• W3172507606 hasLocation W31725076063 @default.
• W3172507606 hasOpenAccess W3172507606 @default.
• W3172507606 hasPrimaryLocation W31725076061 @default.
• W3172507606 hasRelatedWork W1982187894 @default.
• W3172507606 hasRelatedWork W2037755209 @default.
• W3172507606 hasRelatedWork W2070705913 @default.
• W3172507606 hasRelatedWork W2111347914 @default.
• W3172507606 hasRelatedWork W2117290479 @default.
• W3172507606 hasRelatedWork W2138033649 @default.
• W3172507606 hasRelatedWork W2144454494 @default.

• next